Alka Bhatia

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Breast Cancer Cells

Top Venues

Clinical and experimental pharmacology & physiology

Expert review of clinical immunology

Regenerative medicine

Journal of basic and clinical physiology and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Laxmi Kumari, Reena Yadav, Yashwant Kumar, Alka Bhatia
Role of tight junction proteins in shaping the immune milieu of malignancies. Expert review of clinical immunology (2024)
Laxmi Kumari, Reena Yadav, Yashwant Kumar, Alka Bhatia
Role of tight junction proteins in shaping the immune milieu of malignancies. Expert review of clinical immunology (2024)
Ashish Jain, Arti Ralta, Gitika Batra, Rupa Joshi, Nitika Garg, Alka Bhatia, Bikash Medhi, Amitava Chakrabarti, Ajay Prakash
SEW2871 reduces seizures via the sphingosine 1-phosphate receptor-1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug-refractory epilepsy. Clinical and experimental pharmacology & physiology 51 (3) (2024)
Ashish Jain, Arti Ralta, Gitika Batra, Rupa Joshi, Nitika Garg, Alka Bhatia, Bikash Medhi, Amitava Chakrabarti, Ajay Prakash
SEW2871 reduces seizures via the sphingosine 1-phosphate receptor-1 pathway in the pentylenetetrazol and phenobarbitone kindling model of drug-refractory epilepsy. Clinical and experimental pharmacology & physiology 51 (3) (2024)
Banita Thakur, Lekha Saha, Divya Dahiya, Alka Bhatia
Effect of aspirin on the TNF-α-mediated cell survival and death pathways in breast cancer. Journal of basic and clinical physiology and pharmacology (2022)
Banita Thakur, Lekha Saha, Alka Bhatia
Relative refractoriness of breast cancer cells to tumour necrosis factor-α induced necroptosis. Clinical and experimental pharmacology & physiology 49 (12) (2022)
Dhruv Mahendru, Ashish Jain, Seema Bansal, Deepti Malik, Neha Dhir, Amit Raj Sharma, Phulen Sarma, Ajay Prakash, Uma Nahar, Alka Bhatia, Shalmoli Bhattacharyya, Bikash Medhi
Neuroprotective effect of bone marrow-derived mesenchymal stem cell secretome in 6-OHDA-induced Parkinson's disease. Regenerative medicine 16 (10) (2021)